GO:0002575 basophil chemotaxis: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0002575 basophil chemotaxis is defined as the movement of a basophil in response to an external stimulus.
Human basophil chemotaxis was first demonstrated in 1972, establishing basophils as motile cells capable of directed migration.
Basophil chemotaxis is regulated by chemokines such as CXCL12 via CXCR4 and by histamine via the H4 receptor.
Chemokines including interleukin-8 and RANTES promote basophil adhesion to endothelial cells, a prerequisite for tissue migration.
Basophil migration and chemotaxis are implicated in allergic inflammation and airway disease, making them therapeutic targets.
Single-cell transcriptomics of allergic skin inflammation has identified basophil-associated gene signatures relevant to chemotaxis.

Description

Basophils are rare circulating granulocytes that play a central role in allergic inflammation and immune surveillance. The Gene Ontology term GO:0002575, basophil chemotaxis, describes the directed movement of a basophil in response to an external stimulus. This process is fundamental to the recruitment of basophils from the bloodstream into tissues during allergic and inflammatory responses. Understanding basophil chemotaxis is essential for researchers studying allergy, asthma, and other inflammatory diseases, as it represents a key checkpoint in basophil effector function. The first demonstration of human basophil chemotaxis in 1972 established that these cells respond to chemotactic signals, laying the foundation for decades of research into the molecular regulation of basophil migration. Since then, chemokines such as CXCL12 and lipid mediators have been shown to activate basophils and direct their movement. Histamine, a major basophil mediator, also regulates basophil chemotaxis through the H4 receptor, creating a feedback loop that amplifies allergic inflammation. This article provides a comprehensive overview of the mechanisms, genes, and research methods associated with GO:0002575, with a focus on publication-ready, evidence-based content for biomedical researchers.

basophil chemotaxis At A Glance

GO ID GO:0002575
GO term basophil chemotaxis
Ontology biological_process
Synonym none
Major function Directed movement of basophils in response to external stimuli, enabling recruitment to tissues during inflammation and allergy
Key chemokine receptor CXCR4, which mediates basophil activation and chemotaxis in response to CXCL12
Key adhesion molecules Integrins and selectins involved in basophil adhesion to endothelial cells
Regulatory receptor Histamine H4 receptor, which modulates basophil chemotaxis and activation
Associated diseases Allergic inflammation, asthma, atopic dermatitis

What Is GO:0002575?

GO:0002575 basophil chemotaxis is the biological process defined as the movement of a basophil in response to an external stimulus. This includes the directed migration of basophils along chemical gradients, a behavior critical for their recruitment to sites of inflammation and allergic reactions.

Why Is basophil chemotaxis Important in Cell Biology?

Basophil chemotaxis is a critical process in the initiation and amplification of allergic inflammation. Basophils are potent producers of histamine and other mediators, and their directed migration into tissues is essential for their effector functions. Dysregulated basophil chemotaxis contributes to the pathogenesis of allergic diseases such as asthma and atopic dermatitis, making it an attractive target for therapeutic intervention. Understanding the molecular mechanisms of basophil chemotaxis can inform the development of new anti-inflammatory drugs.
Basophil chemotaxis is essential for the recruitment of basophils to sites of allergic inflammation.
It enables basophils to respond to chemokine gradients such as CXCL12 via CXCR4.
Histamine, a major basophil mediator, regulates chemotaxis through the H4 receptor, creating a positive feedback loop.
Basophil migration and adhesion to endothelial cells are prerequisites for tissue infiltration.
Dysregulated basophil chemotaxis is implicated in asthma and airway diseases.
Single-cell transcriptomics of allergic skin inflammation has revealed basophil gene signatures that may influence chemotaxis.
Basophil chemotaxis is a potential therapeutic target for allergic diseases.
Studying basophil chemotaxis helps elucidate general mechanisms of leukocyte migration.
It contributes to host defense against parasites, although this is less well characterized.
Understanding basophil chemotaxis can aid in the development of biomarkers for allergic diseases.

What Happens During basophil chemotaxis?

Sensing Chemotactic Gradients
In simple terms: Basophils detect chemical signals that tell them where to move.
Basophils express G-protein-coupled receptors (GPCRs) that sense chemokines and other chemoattractants. The chemokine CXCL12 activates basophils via CXCR4, inducing intracellular signaling that leads to directed migration. Histamine also acts as a chemoattractant for basophils through the H4 receptor, which is expressed on basophils and mediates chemotaxis. This sensing step is the first stage of basophil chemotaxis, allowing basophils to respond to external stimuli as defined in GO:0002575.
Adhesion to Endothelial Cells
In simple terms: Basophils stick to blood vessel walls before moving into tissues.
Before basophils can migrate into tissues, they must adhere to endothelial cells. Chemokines such as interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers. This adhesion step is critical for basophil extravasation and subsequent chemotaxis to inflammatory sites.
Directed Migration
In simple terms: Basophils move along the chemical trail toward the source.
Once adhered, basophils migrate along chemotactic gradients. Human basophil chemotaxis was first demonstrated in 1972, showing that basophils move directionally in response to external stimuli. This migration is regulated by intracellular signaling pathways downstream of GPCRs, including activation of the histamine H4 receptor. The process is essential for basophil accumulation in allergic tissues.
Amplification by Histamine
In simple terms: Histamine released by basophils attracts more basophils.
Histamine, a major mediator released by basophils, can act in an autocrine or paracrine manner to enhance basophil chemotaxis via the H4 receptor. This creates a positive feedback loop that amplifies basophil recruitment during allergic inflammation. The H4 receptor is therefore a key regulator of basophil chemotaxis and a potential therapeutic target.
Tissue Infiltration and Effector Function
In simple terms: Basophils enter tissues and release inflammatory mediators.
After chemotaxis into tissues, basophils release histamine and other mediators that contribute to allergic inflammation. Single-cell transcriptome profiling of mouse skin undergoing antigen-driven allergic inflammation has recapitulated findings in atopic dermatitis skin lesions, highlighting basophil-associated gene signatures that may influence tissue infiltration. This final stage of basophil chemotaxis is critical for the effector functions of basophils in allergic diseases.

Key Genes Involved in GO:0002575 basophil chemotaxis

The following genes and proteins are key players in basophil chemotaxis, based on published literature.
GeneMajor RoleResearch Relevance
CXCR4Receptor for CXCL12; mediates basophil activation and chemotaxisTarget for modulating basophil recruitment in allergic diseases
CXCL12Chemokine ligand for CXCR4; activates basophilsPotential biomarker or therapeutic target in inflammation
HRH4Histamine H4 receptor; regulates basophil chemotaxis and activationDrug target for allergic inflammation
HRH1Histamine H1 receptor; may contribute to basophil responsesLess studied in basophil chemotaxis
HRH2Histamine H2 receptor; may modulate basophil functionPotential modulator of basophil activity
ITGAMIntegrin alpha-M; involved in adhesionAdhesion molecule for basophil extravasation
ITGB2Integrin beta-2; involved in adhesionAdhesion molecule for basophil extravasation
SELLL-selectin; mediates rolling adhesionPotential target for blocking basophil recruitment
SELEE-selectin; expressed on endothelial cellsMediates basophil adhesion to endothelium
VCAM1Vascular cell adhesion molecule 1; binds integrinsEndothelial adhesion molecule
ICAM1Intercellular adhesion molecule 1; binds integrinsEndothelial adhesion molecule
CCL5RANTES; induces basophil adhesionChemokine involved in basophil recruitment
CXCL8Interleukin-8; induces basophil adhesionChemokine involved in basophil recruitment
FPR1Formyl peptide receptor 1; may mediate chemotaxisPotential chemotaxis receptor
FPR2Formyl peptide receptor 2; may mediate chemotaxisPotential chemotaxis receptor
PLA2G4APhospholipase A2; involved in lipid mediator productionEnzyme for eicosanoid synthesis
PTGS2Cyclooxygenase-2; involved in prostaglandin synthesisEnzyme for eicosanoid synthesis

How Is basophil chemotaxis Regulated?

Basophil chemotaxis is regulated by multiple signaling pathways. The histamine H4 receptor plays a central role, as its activation enhances basophil chemotaxis and activation. Chemokine receptors such as CXCR4 mediate responses to CXCL12, leading to directed migration. Adhesion molecules including integrins and selectins are also regulated during chemotaxis to facilitate endothelial adhesion. Additionally, histamine released by basophils can act in an autocrine manner to amplify chemotaxis via H4 receptors. These regulatory mechanisms ensure that basophils migrate to appropriate sites during allergic inflammation.

basophil chemotaxis and Human Disease

GeneDisease / BiologyPotential Experimental Model
CXCR4Allergic inflammation, asthmaKnockout mouse or human basophil cell line
HRH4Allergic inflammation, asthmaPoint mutation or knockout in basophil cell lines
CCL5Airway inflammationOverexpression in endothelial cells
CXCL8Airway inflammationKnockdown in endothelial cells
ITGB2Leukocyte adhesion deficiencyKnock-in of patient mutations
Allergic Inflammation and Asthma
Basophil chemotaxis is a key contributor to allergic inflammation. Basophils recruited to the airways release histamine and other mediators that exacerbate asthma symptoms. The histamine H4 receptor, which regulates basophil chemotaxis, is a potential therapeutic target for asthma. Chemokines such as CXCL12 and RANTES promote basophil recruitment, and their inhibition may reduce allergic inflammation.
Atopic Dermatitis
Single-cell transcriptome profiling of mouse skin undergoing antigen-driven allergic inflammation has recapitulated findings in atopic dermatitis skin lesions, revealing basophil-associated gene signatures. Basophil chemotaxis likely contributes to skin inflammation in atopic dermatitis, although direct evidence is still emerging.
Other Inflammatory Diseases
Basophil chemotaxis may also play a role in other inflammatory conditions, including chronic urticaria and allergic rhinitis. Granulocyte-targeted therapies for airway diseases are being developed, with basophil chemotaxis as a potential target.

From basophil chemotaxis-Related Genes to Experimental Models

Research QuestionSuitable Model
Does CXCR4 mediate basophil chemotaxis?CXCR4 knockout in human basophil cell line (e.g., KU-812)
Does histamine H4 receptor regulate basophil chemotaxis?HRH4 point mutation or knockout in basophils
What is the role of integrins in basophil adhesion?ITGB2 knockout in basophil cell lines
Can CXCL12-induced chemotaxis be modulated?Overexpression of CXCL12 in endothelial cells
What genes are differentially expressed during basophil chemotaxis?RNA-seq of basophils before and after chemotaxis
Can basophil chemotaxis be visualized in vivo?Tagged knock-in of chemotaxis receptors in mouse models

How to Study the basophil chemotaxis Process

MethodWhat It MeasuresTypical Application
Transwell migration assayDirected migration of basophilsTesting chemotactic response to CXCL12 or histamine
Adhesion assayBasophil adhesion to endothelial cellsStudying integrin-mediated adhesion
Single-cell RNA-seqGene expression profiles of basophilsIdentifying novel chemotaxis regulators
Flow cytometrySurface marker expression and activationQuantifying CXCR4 and H4R levels
ImmunofluorescenceLocalization of basophils in tissuesVisualizing tissue infiltration
ELISAHistamine releaseMeasuring basophil activation
Western blotSignaling protein phosphorylationAssessing GPCR downstream pathways
CRISPR screeningGenes required for chemotaxisIdentifying novel regulators
In Vitro Chemotaxis Assays
Transwell migration assays are commonly used to measure basophil chemotaxis in response to chemokines such as CXCL12 or histamine. Basophils are placed in the upper chamber, and chemoattractants in the lower chamber; migrated cells are counted. This method has been used to demonstrate human basophil chemotaxis since 1972.
Adhesion Assays
Adhesion of basophils to endothelial cell monolayers can be measured using labeled basophils and cytokine-stimulated endothelial cells. This assay helps study the adhesion step of basophil chemotaxis.
Single-Cell Transcriptomics
Single-cell RNA sequencing of allergic skin inflammation models can identify basophil gene signatures and reveal novel regulators of chemotaxis. This approach recapitulates findings in human atopic dermatitis lesions.
Flow Cytometry
Flow cytometry can quantify basophil surface markers and activation status after chemotaxis. It is useful for assessing receptor expression such as CXCR4 and H4R.

How CRISPR Can Be Used to Study GO:0002575 basophil chemotaxis

Knockout

CRISPR knockout of CXCR4 or HRH4 in basophil cell lines can determine their essential roles in chemotaxis. Knockout of adhesion molecules such as ITGB2 can assess their contribution to basophil adhesion.

Point Mutation

Introducing point mutations in HRH4 or CXCR4 can mimic patient variants and test their impact on basophil chemotaxis. This approach helps validate drug targets.

Knock-in

Knock-in of tagged chemotaxis receptors (e.g., CXCR4-GFP) allows real-time visualization of receptor trafficking during basophil chemotaxis. Knock-in of disease-associated mutations can model allergic disorders.

Overexpression

Overexpression of chemokines such as CXCL12 or CCL5 in endothelial cells can enhance basophil adhesion and chemotaxis in co-culture models. This helps study the contribution of the microenvironment to basophil recruitment.

How EDITGENE Supports basophil chemotaxis Research

Researchers studying basophil chemotaxis-related genes often need to determine whether a candidate gene is causally involved in the migration process. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to overexpression models.
Contact EDITGENE today to design your custom CRISPR model for basophil chemotaxis research.

Frequently Asked Questions About basophil chemotaxis

Basophil chemotaxis is the directed movement of basophils in response to external stimuli, as defined by GO:0002575.
Key genes include CXCR4, CXCL12, HRH4, ITGB2, and CCL5.
It is commonly measured using Transwell migration assays and adhesion assays.
Histamine enhances basophil chemotaxis via the H4 receptor, creating a positive feedback loop.
CXCL12, interleukin-8, and RANTES are known to attract basophils.
Yes, basophil chemotaxis contributes to allergic inflammation in asthma.
CXCR4 and histamine H4 receptor are key receptors.
Yes, CRISPR knockout of CXCR4 or HRH4 can elucidate their roles.
The KU-812 basophilic cell line is commonly used.
Allergic inflammation, asthma, and atopic dermatitis.

Conclusion

Basophil chemotaxis (GO:0002575) is a fundamental biological process that drives basophil recruitment to sites of allergic inflammation. Key molecular players include CXCR4, CXCL12, and the histamine H4 receptor, which regulate directed migration and adhesion. Understanding these mechanisms is essential for developing new therapies for asthma and other allergic diseases. EDITGENE provides advanced CRISPR tools to study basophil chemotaxis and accelerate drug discovery.

References

  1. 1. Shute J. 1992. Basophil migration and chemotaxis.. Clin Exp Allergy 22(3):321-3 PMID: 1586872
  2. 2. Leyva-Castillo JM et al.. 2022. Single-cell transcriptome profile of mouse skin undergoing antigen-driven allergic inflammation recapitulates findings in atopic dermatitis skin lesions.. J Allergy Clin Immunol 150(2):373-384 PMID: 35300986
  3. 3. Marquardt DL. 1983. Histamine.. Clin Rev Allergy 1(3):343-51 PMID: 6201253
  4. 4. Kay AB et al.. 1972. Chemotaxis of human basophil leucocytes.. Clin Exp Immunol 11(4):557-63 PMID: 4507993
  5. 5. Jinquan T et al.. 2000. Chemokine stromal cell-derived factor 1alpha activates basophils by means of CXCR4.. J Allergy Clin Immunol 106(2):313-20 PMID: 10932076
  6. 6. Tavares LP et al.. 2020. Granulocyte-targeted therapies for airway diseases.. Pharmacol Res 157:104881 PMID: 32380052
  7. 7. Bacon KB et al.. 1994. Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers.. Immunology 82(3):473-81 PMID: 7525460
  8. 8. Mommert S et al.. 2016. Human basophil chemotaxis and activation are regulated via the histamine H4 receptor.. Allergy 71(9):1264-73 PMID: 26948974
Contact Us
*
*
*
*
How did you hear about us: